24-h uric acid excretion and the risk of kidney stones

Kidney International

Volumn 73, Issue 4, 2008, Pages 489-496

  Curhan, G C ^a,b   Taylor, E N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Kidney stone

Indexed keywords

CALCIUM; CALCIUM OXALATE; CITRIC ACID; CREATININE; MAGNESIUM; OXALIC ACID; PHOSPHATE; POTASSIUM; SODIUM; URIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCIUM OXALATE STONE; CALCIUM URINE LEVEL; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PRIORITY JOURNAL; RISK ASSESSMENT; SEX RATIO; STATISTICAL SIGNIFICANCE; URIC ACID URINE LEVEL; URINARY EXCRETION; URINE VOLUME;

EID: 38749152858     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002708     Document Type: Article

References (17)

1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med 1992; 327: 1141-1152.
2. Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 1974; 291: 1344-1350.
3. Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 1978; 13: 418-426.
4. Grover PK, Ryall RL. Urate and calcium oxalate stones: from repute to rhetoric to reality. Miner Electrolyte Metab 1994; 20: 361-370.
5. Ettinger B, Tang A, Citron JT et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986; 315: 1386-1389.
6. Ettinger B. Does hyperuricosuria play a role in calcium oxalate lithiasis? J Urol 1989; 141: 738-741.
7. Curhan GC, Willett WC, Speizer FE et al. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001; 59: 2290-2298.
8. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115: 2598-2608.
9. Fellstrom B, Backman U, Danielson B et al. Urinary excretion of urate in renal calcium stone disease and in renal tubular acidification disturbances. J Urol 1982; 127: 589-592.
10. Pylypchuk G, Ehrig U, Wilson DR. Idiopathic calcium nephrolithiasis 1. Differences in urine crystalloids, urine saturation with brushite and urine inhibitors of calcification between persons with and persons without recurrent kidney stone formation. Can Med Assoc J 1979; 120: 658-665.
11. Farquharson CA, Butler R, Hill A et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002; 106: 221-226.
12. Cardillo C, Kilcoyne CM, Cannon III RO et al. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension 1997; 30: 57-63.
13. Butler R, Morris AD, Belch JJ et al. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746-751.
14. Guthikonda S, Sinkey C, Barenz T et al. Xanthine oxidase inhibition reverses endothelial dysfunction in heavy smokers. Circulation 2003; 107: 416-421.
15. Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int 1982; 22: 292-296.
16. Zimmermann DJ, Voss S, von Unruh GE et al. Importance of magnesium in absorption and excretion of oxalate. Urol Int 2005; 74: 262-267.
17. Erickson SB, Cooper K, Broadus AE et al. Oxalate absorption and postprandial urine supersaturation in an experimental human model of absorptive hypercalciuria. Clin Sci (Lond) 1984; 67: 131-138.